MyControl - A new website to raise awareness about obesity among healthcare professionals and patients
Today, Navamedic launches MyControl – a new website targeted towards both the general public & healthcare professionals to raise awareness about obesity and its treatments.
This is the first step in a wave of communication as part of Navamedic’s effort to increase knowledge about obesity, and to address the fact that obesity is a disease and hence should be treated as one.
“This is a milestone in our attempt to highlight the complexity surrounding this disease and the treatment options available. This is still an underdiagnosed area and we are committed to putting it on the agenda among Clinicians and General Practitioners, our first line of treatment personnel,” says Kathrine Gamborg Andreassen, CEO of Navamedic.
The site, which highlights causes and risks as well as the benefits of a long-term weight loss, places great focus on the brain’s role in developing and mastering the disease and, in addition to current treatment options, also addresses the importance of the right treatment. The website is currently available in Norwegian and Swedish.
For further information, please contact:
Kathrine Gamborg Andreassen, CEO
Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (ticker: NAVA). For more information, please visit www.navamedic.com